Tadalafil (Cialis) 10g

Tadalafil profile:

Class: Phosphodiesterase Type 5 Inhibitors
VA Class: GU900
Chemical Name: (6R,12aR) - 6 - (1,3 - benzodioxol - 5 - yl) - 2,3,6,7,12,12a - hexahydro - 2 - methylpyrazino[1′,2′:1,6]pyrido[3,4 - b]indole - 1,4 - dione
Molecular Formula: C22H19N3O4
CAS Number: 171596-29-5
Brands: Cialis, Adcirca

Tadalafil is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED) under the name Cialis, and under the name Adcirca for the treatment of pulmonary arterial hypertension. In October 2011 the U.S. Food and Drug Administration (FDA) approved Cialis for treating the signs and symptoms of benign prostatic hyperplasia (BPH) as well as a combination of BPH and erectile dysfunction (ED) when the conditions coincide. It initially was developed by the biotechnology company ICOS, and then again developed and marketed world-wide by Lilly ICOS, LLC, the joint venture of ICOS Corporation and Eli Lilly and Company. Cialis tablets, in 5 mg, 10 mg, and 20 mg doses, are yellow, film-coated, and almond-shaped. The approved dose for pulmonary arterial hypertension is 40 mg (two 20-mg tablets) once daily.